image

Regeneron Pharmaceuticals, Inc. - Company Information

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines fo...Read more

Biotech & Pharmaceuticals
  • icon
    Headquarters

    Tarrytown, New York, United States

  • icon
    Contact

    Unlock contact

  • icon
    Linkedin

    linkedin icon

  • icon
    Company Size

    10,000+

  • icon
    Stock Symbol

    REGN

  • icon
    Website

    regeneron.com

  • icon
    Type

    Public

icon

Regeneron Pharmaceuticals, Inc. Technology Stack

Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by Regeneron Pharmaceuticals, Inc.

image

Claris FileMaker

thumbs_up

thumbs_down

Claris FileMaker is a cross-platform relational database application from Claris Internati...

See more technologies

Regeneron Pharmaceuticals, Inc. Employee Profiles

Are you looking for the decision-makers at Regeneron Pharmaceuticals, Inc.? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Regeneron Pharmaceuticals, Inc.’s employee details in less than 30 secs.

Sign-up for 6sense Revenue AI™ for Sales

To find emails, direct dials, and more for prospects across the web.

Sign Up Today

Regeneron Pharmaceuticals, Inc. Competitors

Discover Regeneron Pharmaceuticals, Inc. alternatives or similar companies to benchmark and competitors market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.

image

Lufax Holding Ltd American

  • icon
    Total Employees

    10,000+

  • icon
    Location

    Shanghai

  • icon
    Website

    lufaxholding.com

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

TSFAT EDUCATION FUND INC

  • icon
    Total Employees

    0 - 9

  • icon
    Location

    Tarrytown

  • icon
    Website

    tsfat.com

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    N/A

image

amexval.mx

  • icon
    Total Employees

    10,000+

  • icon
    Location

    Mexico City

  • icon
    Website

    amexval.mx

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    N/A

image

Methodist Healthcare System

  • icon
    Total Employees

    10,000+

  • icon
    Location

    San Antonio

  • icon
    Website

    sahealth.com

  • icon
    Type

    Public

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

914 Smiles

  • icon
    Total Employees

    0 - 9

  • icon
    Location

    Tarrytown

  • icon
    Website

    914smiles.com

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

Download the 6sense Chrome Extension to get verified contact data of Regeneron Pharmaceuticals, Inc. employees

Install Now
Company Logo

Regeneron Pharmaceuticals, Inc. News & Press Releases

Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Regeneron Pharmaceuticals, Inc. latest news, alerts and updates.

Regeneron promotes Christopher Fenimore to CFO, announces board changes

While the company added Kathryn Guarini, PhD and David P. Schenkein, MD to its board, Regeneron announced the departure of Marc Tessier-Lavigne, PhD effective September 1.

Date Icon

11 Sep 2023

Regeneron to acquire Decibel Therapeutics for $109 million

6 unusual side effects of medicines Regeneron Pharmaceuticals has agreed to acquire Decibel Therapeutics, a clinical- stage biotechnology company specializing in therapies to restore and improve hearing and balance, for an up-front payment of $109 million.

Date Icon

21 Aug 2023

Regeneron Pharmaceuticals to acquire Decibel Therapeutics in $109 million deal

Regeneron Pharmaceuticals agreed to acquire Decibel Therapeutics for $4 a share, marking a 43% premium from yesterday's closing price. The U.S. Regeneron Pharmaceuticals The Tarrytown, N.Y.-based company said the deal gives Decibel a total equity value of about $109 million based on the amount payable at closing,

Date Icon

10 Aug 2023

Regeneron To Acquire Decibel Therapeutics

By Dean Seal Regeneron Pharmaceuticals agreed to acquire Decibel Therapeutics for $4 a share, marking a 43% premium from yesterday's closing price.

Date Icon

9 Aug 2023

FAQs for Regeneron Pharmaceuticals, Inc.

Explore frequently asked questions about Regeneron Pharmaceuticals, Inc.’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.

What is Regeneron Pharmaceuticals, Inc.'s official website?

The official website of Regeneron Pharmaceuticals, Inc. is regeneron.com You can find their contact number, email address, and headquarters by clicking here.

faq icon

How many employees are working at Regeneron Pharmaceuticals, Inc.?

faq icon

What industry is Regeneron Pharmaceuticals, Inc. in?

faq icon

What is Regeneron Pharmaceuticals, Inc.'s tech stack?

faq icon

Where are Regeneron Pharmaceuticals, Inc.'s headquarters?

faq icon

Get instant access to B2B contact data across the web

Sign Up Today
6sense Logo
social iconssocial iconssocial iconssocial icons
MarketingAccount IdentificationIntent DataData Enrichment & ManagementPredictive AnalyticsOrchestrations & WorkflowsAudience BuildingAdvertisingConversational EmailPipeline IntelligenceIntegrations
SolutionsBusiness ServicesFinancial ServicesTransportation & LogisticsManufacturingTechnologyCustomersMeet Our CustomersCustomer StoriesCustomer ReviewsRevCityKnowledge Base

Company

AboutLeadership TeamCareersNewsroomCommunity

Browse 6sense Data

TechnographicsComparing TechnologiesCompany SearchPeople Search
TermsPrivacy PolicyPrivacy CenterDo Not Sell or Share My Personal Information

© 2024 6sense